Preservatives may have weakened, and the peptide may have lost potency, which could compromise your safety or the effectiveness of your treatment
Psychological factors: Weight-related body image issues and reduced confidence can contribute to sexual dysfunction
In the case of GLP-1 receptor agonists, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), microdosing involves using a fraction of the typical dose to achieve benefits with potentially fewer side effects
For eligible patients, Semaglutide GLP-1 injections offer a path toward better overall health, reduced weight, and a decreased risk of associated diseases, all while providing a well-tolerated and clinically proven treatment option
World Health Organization (WHO)